Diabetes app mySugr acquired by drugmaker Roche

jkeane90@gmail.com

Austrian healthtech startup, mySugr, which makes a diabetes management app, has been acquired by Swiss medical multinational Roche. No terms for the deal were announced.

The Vienna-based startup was purchased 100% by the Swiss health industry giant. The app’s tech will help inform Roche’s digital strategy for the diabetes market moving forward. “[The deal] means that we, people with diabetes, will be in the driver’s seat, supported by the global leader in diabetes therapy,” said mySugr in a statement. mySugr will continue to operate on its own.

The app is used by diabetics to track their condition in between doctor visits. It has one million users globally.

Prior to the acquisition, Roche’s venture fund had invested in the startup, which has raised over $6 million in total VC funding.

Share this:
Share on linkedin
Share on facebook
Share on twitter

Get exclusive access to news, data and actionable insights on the European Tech innovation ecosystem(s)

By subscribing to Tech.eu, you gain instant access to curated European technology news, market intelligence and interviews with leading startup founders, investors and more. Sign up now in under a minute to deepen your knowledge on the European Tech innovation ecosystems on a daily basis.